Biotechnology company Moderna is preparing to begin human trials on HIV vaccines as early as Wednesday using the same mRNA platform as the firm’s COVID-19 vaccine. Read More
Moderna’s HIV Vaccine to Start Human Trials Early As Wednesday, Uses mRNA Like COVID Shot
Reading Time: minute